Cargando…

Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials

BACKGROUND: Chronic obstructive pulmonary disease (COPD) clinical trials aimed at evaluating treatment effects on exacerbations often suffer from early discontinuations of randomized treatment. Treatment discontinuations imply a loss of information and should ideally be considered in the statistical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Król, Agnieszka, Palmér, Robert, Rondeau, Virginie, Rennard, Stephen, Eriksson, Ulf G., Jauhiainen, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310001/ https://www.ncbi.nlm.nih.gov/pubmed/32571311 http://dx.doi.org/10.1186/s12931-020-01419-8

Ejemplares similares

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)
por: Vogelmeier, Claus F., et al.
Publicado: (2015)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]
Publicado: (2022)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study
por: Wedzicha, Jadwiga A., et al.
Publicado: (2019)

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
por: Chen, Yahong, et al.
Publicado: (2020)

COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV(1) – a post-hoc analysis of pooled data
por: Chai, Chee-Shee, et al.
Publicado: (2023)

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2019)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study
por: Singh, Dave, et al.
Publicado: (2017)

Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Acute COPD exacerbation treatment with noninvasive ventilation
por: Ralf, Ewert, et al.
Publicado: (2023)

Is discontinuation of dental treatment related to exacerbation of systemic medical diseases in Japan?
por: Enomoto, Akifumi, et al.
Publicado: (2023)

Exacerbations in the pre- and post-COPD diagnosis periods
por: Yawn, Barbara P, et al.
Publicado: (2013)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
por: Liu-Seifert, Hong, et al.
Publicado: (2005)

Icenticaftor, Novel Therapy for COPD: This Glass Is Half Full
por: Rennard, Stephen I.
Publicado: (2023)

Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods
por: Morrow, Jarrett D, et al.
Publicado: (2015)

Airways inflammation and treatment during acute exacerbations of COPD
por: Bathoorn, Erik, et al.
Publicado: (2008)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
por: Patel, Naimish R, et al.
Publicado: (2018)

Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF
por: Ungar, Leo, et al.
Publicado: (2019)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
por: Harries, Timothy H., et al.
Publicado: (2020)

Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
por: Hill, Andrew R., et al.
Publicado: (2023)

A stochastic mixed effects model to assess treatment effects and fluctuations in home‐measured peak expiratory flow and the association with exacerbation risk in asthma
por: Leander, Jacob, et al.
Publicado: (2021)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation
por: Frenkel, Amit, et al.
Publicado: (2019)

Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses
por: Cosman, Felicia, et al.
Publicado: (2022)

Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
por: Lioudis, Michael, et al.
Publicado: (2023)

Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study
por: Mahler, Donald A, et al.
Publicado: (2023)

Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis
por: Zheng, Jin-Ping, et al.
Publicado: (2019)

Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials
por: Kawahara, Takuya, et al.
Publicado: (2022)

COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
por: Leung, Janice M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cnhvls5s21t7np96vphm0peetc